Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean F Bajorin

Showing results (11-20 of 169) with videos related to

Pageof 17
Sort By:
Urology|November 8, 2011
New data, new paradigms for treating prostate cancer patients--VI: novel hormonal therapy approachesRobert Dreicer, Dean F Bajorin, David G McLeod, et al.
Cancer|January 4, 2007
Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal functionMatthew D Galsky, Alexia Iasonos, Svetlana Mironov, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 4, 2008
Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSFPadmanee Sharma, Dean F Bajorin, Achim A Jungbluth, et al.
Journal of Oncology Practice|May 2, 2013
Tracking the workforce: the American Society of Clinical Oncology workforce information systemM Kelsey Kirkwood, Michael P Kosty, Dean F Bajorin, et al.
Investigational New Drugs|December 6, 2006
Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinomaMatthew D Galsky, Svetlana Mironov, Alexia Iasonos, et al.
Journal of Oncology Practice|January 21, 2014
Enhancing the American Society of Clinical Oncology workforce information system with geographic distribution of oncologists and comparison of data sources for the number of practicing oncologistsM Kelsey Kirkwood, Suanna S Bruinooge, Michael A Goldstein, et al.
Urology|October 11, 2003
Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcomeJames M McKiernan, Robert J Motzer, Dean F Bajorin, et al.
The Journal of Urology|July 12, 2005
Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasionAndrew J Stephenson, George J Bosl, Dean F Bajorin, et al.
The Journal of Urology|February 8, 2002
Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancerHarry W Herr, Bernard H Bochner, Guido Dalbagni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2007
Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancerAndrew J Stephenson, George J Bosl, Robert J Motzer, et al.
Pageof 17

Showing results (11-20 of 169) with videos related to

Sort By:
Pageof 17
Urology|November 8, 2011
New data, new paradigms for treating prostate cancer patients--VI: novel hormonal therapy approachesRobert Dreicer, Dean F Bajorin, David G McLeod, et al.
Cancer|January 4, 2007
Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal functionMatthew D Galsky, Alexia Iasonos, Svetlana Mironov, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 4, 2008
Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSFPadmanee Sharma, Dean F Bajorin, Achim A Jungbluth, et al.
Journal of Oncology Practice|May 2, 2013
Tracking the workforce: the American Society of Clinical Oncology workforce information systemM Kelsey Kirkwood, Michael P Kosty, Dean F Bajorin, et al.
Investigational New Drugs|December 6, 2006
Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinomaMatthew D Galsky, Svetlana Mironov, Alexia Iasonos, et al.
Journal of Oncology Practice|January 21, 2014
Enhancing the American Society of Clinical Oncology workforce information system with geographic distribution of oncologists and comparison of data sources for the number of practicing oncologistsM Kelsey Kirkwood, Suanna S Bruinooge, Michael A Goldstein, et al.
Urology|October 11, 2003
Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcomeJames M McKiernan, Robert J Motzer, Dean F Bajorin, et al.
The Journal of Urology|July 12, 2005
Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasionAndrew J Stephenson, George J Bosl, Dean F Bajorin, et al.
The Journal of Urology|February 8, 2002
Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancerHarry W Herr, Bernard H Bochner, Guido Dalbagni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2007
Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancerAndrew J Stephenson, George J Bosl, Robert J Motzer, et al.
Pageof 17